3,050 Shares of Stryker Corporation $SYK Bought by Skylands Capital LLC

Skylands Capital LLC purchased a new position in shares of Stryker Corporation (NYSE:SYK) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 3,050 shares of the medical technology company’s stock, valued at approximately $840,000.

A number of other large investors have also bought and sold shares of SYK. Gables Capital Management Inc. purchased a new stake in shares of Stryker during the second quarter valued at approximately $25,000. Kilter Group LLC purchased a new position in shares of Stryker in the second quarter worth $25,000. Highland Investment Advisors LLC purchased a new position in shares of Stryker in the second quarter worth $25,000. Cornerstone Financial Management LLC raised its holdings in Stryker by 66.0% during the 2nd quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after buying an additional 31 shares during the last quarter. Finally, Compass Financial Management LLC bought a new stake in Stryker during the 2nd quarter valued at $27,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Stryker

In other Stryker news, insider Debra King sold 826 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the sale, the insider directly owned 6,210 shares in the company, valued at $2,088,423. This trade represents a 11.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Ronda E. Stryker sold 300,000 shares of Stryker stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the sale, the director directly owned 2,301,375 shares in the company, valued at approximately $773,031,862.50. The trade was a 11.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 351,267 shares of company stock worth $118,197,701 over the last 90 days. 4.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on SYK shares. BMO Capital Markets reissued an “outperform” rating and set a $317.00 price target on shares of Stryker in a research report on Wednesday, September 9th. Citigroup decreased their price objective on shares of Stryker from $399.00 to $360.00 and set a “buy” rating on the stock in a research report on Thursday, September 10th. Royal Bank Of Canada decreased their price objective on shares of Stryker from $435.00 to $420.00 and set an “outperform” rating on the stock in a research report on Friday, July 31st. Evercore set a $350.00 price objective on shares of Stryker in a research note on Monday, July 6th. Finally, Stifel Nicolaus lowered their price objective on shares of Stryker from $360.00 to $330.00 and set a “buy” rating for the company in a research note on Wednesday, September 30th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $369.00.

Stryker Stock Performance

NYSE:SYK opened at $297.30 on Thursday. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The firm’s fifty day simple moving average is $296.53 and its 200 day simple moving average is $312.13. The stock has a market cap of $114.03 billion, a P/E ratio of 30.81, a price-to-earnings-growth ratio of 1.96 and a beta of 0.78. Stryker Corporation has a twelve month low of $267.00 and a twelve month high of $392.55.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. During the same period in the prior year, the business earned $3.13 EPS. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, research analysts predict that Stryker Corporation will post 14.93 EPS for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.2%. Stryker’s payout ratio is currently 36.48%.

Stryker Company Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.